The Mark Foundation for Cancer Research (MFCR), The Leukemia & Lymphoma Society (LLS), and The Paul G. Allen Frontiers Group (PAFG) are proud to announce the Blood Cancer Discoveries Grant Program, a new research award program designed to encourage basic research, technological innovation, and informatics pipeline development that can lead to an understanding of blood cancer disease mechanisms, the development of improved methods for detecting and monitoring cancer progression, and the identification of novel therapeutic targets.
MFCR, LLS and PAFG are sponsoring and issuing this Request for Applications (RFA) from independent academic investigators for support of foundational, early stage research that can lead to advances in the treatment and cure of blood cancers. MFCR, LLS and PAFG recognize the need for a dedicated mechanism to encourage established investigators to explore the biology of blood cancer and support proof-of-concept studies that could initiate completely novel approaches to treatment.
Letters of Intent (LOIs) are due September 3, 2019 at 3 PM ET through the LLS Research Portal, Fluxx. Click here to apply!